Caulis, Inc. (JP:153A)
:153A
Want to see JP:153A full AI Analyst Report?
Top Page
Caulis, Inc.
(153A)
Select Model
Select Model
Rating:76Outperform
Price Target:
¥2,269.00
▲(6.58% Upside)
Action:Reiterated
Date:05/01/26
The score is driven primarily by strong financial performance (fast growth, solid margins, and sharply improved leverage) and a supportive technical uptrend. Valuation is the main restraint, with a higher P/E and a low dividend yield reducing upside cushion.
Positive Factors
Revenue Growth
A >100% revenue acceleration in 2025 indicates strong product-market fit and demand expansion. Durable revenue growth supports reinvestment, economies of scale, and long-term market share gains, reducing reliance on short-term promotions or one-off contracts.
Negative Factors
Cash Generation Volatility
Operating cash flow fell despite higher revenue and cash conversion from earnings is moderate (~0.40), while free cash flow has declined. This volatility can constrain funding for capex, M&A, or shareholder returns and increases execution risk over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
A >100% revenue acceleration in 2025 indicates strong product-market fit and demand expansion. Durable revenue growth supports reinvestment, economies of scale, and long-term market share gains, reducing reliance on short-term promotions or one-off contracts.
Read all positive factors
Caulis, Inc. (153A) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥11.31B
Dividend YieldN/A
Average Volume (3M)92.42K
Price to Earnings (P/E)21.4
Beta (1Y)1.47
Revenue Growth15.99%
EPS Growth-2.02%
CountryJP
Employees42
SectorTechnology
Sector Strength88
IndustrySoftware - Application
Share Statistics
EPS (TTM)22.79
Shares Outstanding6,534,800
10 Day Avg. Volume64,850
30 Day Avg. Volume92,423
Financial Highlights & Ratios
PEG Ratio-7.19
Price to Book (P/B)4.57
Price to Sales (P/S)5.41
P/FCF Ratio36.86
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Caulis, Inc. Business Overview & Revenue Model
Company Description
Caulis, Inc. (153A) is a biotechnology company specializing in the development of innovative agricultural solutions and biopesticides aimed at enhancing crop productivity and sustainability. The company focuses on harnessing natural plant-based co...
How the Company Makes Money
null...
Caulis, Inc. Financial Statement Overview
Summary
Income Statement
86
Very Positive
Balance Sheet
83
Very Positive
Cash Flow
74
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 670.56M | 1.40B | 1.23B | 995.00M | 769.47M | 489.21M |
| Gross Profit | 422.33M | 817.28M | 773.80M | 611.61M | 493.95M | 253.06M |
| EBITDA | 224.33M | 415.15M | 415.80M | 300.80M | 220.91M | 19.99M |
| Net Income | 145.63M | 276.44M | 276.30M | 260.37M | 249.96M | 13.46M |
Balance Sheet | ||||||
| Total Assets | 2.21B | 2.18B | 2.02B | 1.18B | 718.30M | 481.51M |
| Cash, Cash Equivalents and Short-Term Investments | 1.88B | 1.49B | 1.73B | 954.70M | 604.11M | 431.24M |
| Total Debt | 250.00M | 100.00M | 250.00M | 301.00M | 250.00M | 290.00M |
| Total Liabilities | 745.17M | 525.67M | 708.52M | 727.04M | 527.01M | 538.44M |
| Stockholders Equity | 1.47B | 1.66B | 1.32B | 451.66M | 191.28M | -56.93M |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 205.42M | 265.90M | 299.58M | 212.86M | 117.33M |
| Operating Cash Flow | 0.00 | 208.97M | 266.22M | 306.55M | 215.42M | 119.36M |
| Investing Cash Flow | 0.00 | -373.80M | -322.00K | -6.95M | -2.56M | -2.02M |
| Financing Cash Flow | 0.00 | -81.20M | 512.50M | 51.00M | -40.00M | -2.50M |
Caulis, Inc. Technical Analysis
Positive
2129.00
Price Trends
1369.98
Positive
1276.72
Positive
1625.59
Positive
Market Momentum
128.02
Negative
56.99
Neutral
61.81
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:153A, the sentiment is Positive. The current price of 2129 is above the 20-day moving average (MA) of 1662.05, above the 50-day MA of 1369.98, and above the 200-day MA of 1625.59, indicating a bullish trend. The MACD of 128.02 indicates Negative momentum. The RSI at 56.99 is Neutral, neither overbought nor oversold. The STOCH value of 61.81 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:153A.
Caulis, Inc. Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥11.31B | 21.42 | ― | ― | 15.99% | -2.02% | |
67 Neutral | ¥9.51B | 5.52 | ― | 0.70% | 12.98% | 80.52% | |
66 Neutral | ¥6.17B | 22.68 | ― | 0.57% | 32.11% | -0.12% | |
62 Neutral | ¥4.45B | 25.26 | ― | ― | 6.84% | -67.48% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
60 Neutral | ¥6.08B | 20.75 | ― | ― | 18.87% | ― | |
57 Neutral | ¥4.55B | 49.92 | ― | ― | 18.48% | -48.49% |
* Technology Sector Average
JP:153A
Caulis, Inc.
1,731.00
351.41
25.47%
JP:4060
rakumo Inc.
1,058.00
223.58
26.79%
JP:4168
Yappli, Inc.
732.00
-14.02
-1.88%
JP:4397
TeamSpirit, Inc.
368.00
-56.00
-13.21%
JP:4484
Lancers, Inc.
280.00
72.37
34.86%
JP:5033
Nulab Inc.
687.00
-161.00
-18.99%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.